#Japan #FDA #Hamamatsu #NanoZoomer

Hamamatsu Achieves FDA 510(k) Clearance for New NanoZoomer Models

Hamamatsu Photonics K.K., a leader in photonics technology, has made significant strides in the field of digital pathology by announcing the receipt of FDA 510(k) clearance for two advanced slide scanner systems: the NanoZoomer S20MD and the S540MD. This announcement, dated September 2, 2026, marks a notable enhancement to the already established NanoZoomer product line, particularly following the prior approval of the NanoZoomer S360MD.

The FDA 510(k) clearance allows clinical pathology laboratories in the United States to select from a broader range of FDA-cleared NanoZoomer systems based on their unique operational needs. This new expansion underscores Hamamatsu's commitment to delivering diverse solutions that meet the evolving demands of the medical field.

Expansion of Features and Applications

With the FDA clearances, Hamamatsu now offers three robust options within its NanoZoomer portfolio:
1. NanoZoomer S20MD - Ideal for compact benchtop settings, it is designed for laboratories requiring a space-efficient yet powerful solution.
2. NanoZoomer S360MD - Focused on routine laboratory workflows, this model serves as a reliable choice for standard pathology practices.
3. NanoZoomer S540MD - Aimed at high-throughput laboratory operations, it meets the needs of labs that handle large volumes of slide scanning efficiently.

This comprehensive approach to pathologic imaging provides laboratories with the flexibility to choose systems based on their specific volume and function requirements. The synergy among the different models ensures a consistent experience throughout the NanoZoomer family, enabling pathologists and lab technicians to operate seamlessly as they switch between systems.

Commitment to Quality and Innovation

Scott Blakely, Business Development Manager for the Americas, commented on these FDA clearances, stating that they represent an essential milestone for Hamamatsu. He emphasized the company's dedication to providing high-quality imaging solutions that exhibit reliability and long-term performance, key characteristics of the NanoZoomer platform.

The NanoZoomer series has long been recognized for its cutting-edge technology in whole slide imaging, particularly valuable for pathology research. Over the past two decades, these digital scanners have set the standard in their field, enabling medical professionals to conduct thorough examinations with high-resolution images.

About Hamamatsu Photonics K.K.

Hamamatsu Photonics K.K. specializes in the design and manufacturing of photonic devices, ranging from optical sensors to imaging systems. As a pioneer in the industry, the company provides critical components that cater to various demanding markets, ensuring that medical laboratories have access to the latest technology.

By broadening its FDA-cleared offerings with the S20MD and S540MD models, Hamamatsu not only enhances its position in the market but also empowers clinicians with superior tools to aid in diagnostics and treatment strategies.

For more details about the NanoZoomer series and other products, you can visit their official website at www.nanozoomer.com.

As the landscape of digital pathology evolves, Hamamatsu Photonics K.K. continues to be a dependable partner for laboratories seeking innovation, quality, and efficiency in their operations.